AU2018314406B2 - Nanoemulsion of iodinated fatty acids for CT imaging - Google Patents

Nanoemulsion of iodinated fatty acids for CT imaging Download PDF

Info

Publication number
AU2018314406B2
AU2018314406B2 AU2018314406A AU2018314406A AU2018314406B2 AU 2018314406 B2 AU2018314406 B2 AU 2018314406B2 AU 2018314406 A AU2018314406 A AU 2018314406A AU 2018314406 A AU2018314406 A AU 2018314406A AU 2018314406 B2 AU2018314406 B2 AU 2018314406B2
Authority
AU
Australia
Prior art keywords
contrast agent
emulsion
vivo imaging
fatty acids
iodinated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018314406A
Other languages
English (en)
Other versions
AU2018314406A1 (en
Inventor
Eric Allemann
Andrej Babic
Laurent VINET
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Geneve
Original Assignee
Universite de Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Geneve filed Critical Universite de Geneve
Publication of AU2018314406A1 publication Critical patent/AU2018314406A1/en
Assigned to UNIVERSITÉ DE GENÈVE reassignment UNIVERSITÉ DE GENÈVE Amend patent request/document other than specification (104) Assignors: UNIVERSITY OF GENEVA
Application granted granted Critical
Publication of AU2018314406B2 publication Critical patent/AU2018314406B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Medicinal Preparation (AREA)
AU2018314406A 2017-08-07 2018-07-27 Nanoemulsion of iodinated fatty acids for CT imaging Active AU2018314406B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17185185.0 2017-08-07
EP17185185 2017-08-07
PCT/EP2018/070501 WO2019030024A1 (en) 2017-08-07 2018-07-27 NANOEMULSION OF IODIZED FATTY ACIDS FOR COMPUTER-ASSISTED TOMOGRAPHY (CT) IMAGING

Publications (2)

Publication Number Publication Date
AU2018314406A1 AU2018314406A1 (en) 2020-02-20
AU2018314406B2 true AU2018314406B2 (en) 2024-08-15

Family

ID=59564118

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018314406A Active AU2018314406B2 (en) 2017-08-07 2018-07-27 Nanoemulsion of iodinated fatty acids for CT imaging

Country Status (9)

Country Link
US (1) US11654202B2 (enExample)
EP (1) EP3664855A1 (enExample)
JP (1) JP7210542B2 (enExample)
CN (1) CN111194225B (enExample)
AU (1) AU2018314406B2 (enExample)
BR (1) BR112020002619A2 (enExample)
CA (1) CA3072282A1 (enExample)
EA (1) EA202090139A1 (enExample)
WO (1) WO2019030024A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113784734B (zh) * 2019-02-13 2024-09-27 日内瓦大学 用于恶病质的检测的ct造影剂
JP2023536358A (ja) * 2020-08-06 2023-08-24 アディポス エスエー Ｐｅｔ－ｃｔ撮像方法、その撮像方法における使用のための造影剤および医薬組成物
CN112933246A (zh) * 2020-12-17 2021-06-11 太阳雨林（厦门）生物医药有限公司 一种可显影的油制剂及其制备方法
US20240336552A1 (en) * 2021-08-02 2024-10-10 Microvention, Inc. Compounds
EP4423211A1 (en) 2021-10-28 2024-09-04 Adiposs SA Emulsions, compositions for emulsions, methods for making the same and uses thereof
WO2025079088A1 (en) * 2023-10-11 2025-04-17 Bioroot Exploration India Private Limited A contrast agent for computed tomography and process of preparation thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258172A (en) * 1983-12-29 1993-11-02 Rubin Daniel L Iodinated aliphatic emulsions for X-ray contrast
DE3785849T2 (de) 1987-06-11 1993-08-26 Kabi Pharmacia Ab Jod enthaltende emulsion.
US5861367A (en) 1993-08-04 1999-01-19 Colgate Palmolive Company Cleaning and disinfecting composition in microemulsion/liquid crystal form comprising aldehyde and mixture of partially esterified, fully esterified and non-esterified polyhydric alcohols
FR2736549B1 (fr) 1995-07-11 1997-10-10 Louis Jung Esters d'acides gras iodes, acides gras iodes et leurs derives, obtenus par iodohydrination faisant intervenir des derives alkylsilyles avec des iodures alcalins et leurs activites pharmacologiques
DE19936727A1 (de) 1999-08-06 2001-02-08 Henkel Kgaa Niotensidbasiertes wäßriges mehrphasiges Reinigungsmittel
US20050079131A1 (en) * 2003-08-08 2005-04-14 Lanza Gregory M. Emulsion particles for imaging and therapy and methods of use thereof
GB0408684D0 (en) 2004-04-19 2004-05-19 Guy S And St Thomas Hospital N Diagnostic method
SG10201505948VA (en) 2004-12-13 2015-09-29 Amylin Pharmaceuticals Llc Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same
ATE496881T1 (de) 2006-02-15 2011-02-15 Ge Healthcare As Kontrastmittel
US20080319315A1 (en) 2007-06-07 2008-12-25 Beth Israel Deaconess Medical Center Method of reducing interferences in positron emission tomography
US20140065067A1 (en) 2010-12-17 2014-03-06 Universite De Strasbourg Radiopaque iodinated products intended for use medical imaging and their methods
KR101263733B1 (ko) 2011-03-22 2013-05-14 한국과학기술연구원 리피오돌을 함유하는 컴퓨터 단층촬영용 혈관 조영제
CN102166365B (zh) 2011-04-25 2012-10-24 东南大学 一种多模态碘油纳米乳造影剂的制备方法
DE102012204378A1 (de) 2012-03-20 2013-09-26 Bernd Schwegmann Gmbh & Co. Kg Reinigungsmittel auf Mikroemulsionsbasis
CN105592862B (zh) 2013-09-30 2020-09-29 贝朗医疗有限公司 肝脏预饱和及其后造影剂的施用
WO2015127347A1 (en) 2014-02-24 2015-08-27 The Regents Of The University Of California Therapeutic hyperbranched polyglycerol encapsulated biomolecules
US10157462B2 (en) 2016-06-27 2018-12-18 University Of Central Florida Research Foundation, Inc. System and method for image-based quantification of white and brown adipose tissue at the whole-body, organ and body-region levels

Also Published As

Publication number Publication date
JP2020529441A (ja) 2020-10-08
EP3664855A1 (en) 2020-06-17
EA202090139A1 (ru) 2020-08-06
AU2018314406A1 (en) 2020-02-20
WO2019030024A1 (en) 2019-02-14
CN111194225B (zh) 2023-01-13
CA3072282A1 (en) 2019-02-14
CN111194225A (zh) 2020-05-22
JP7210542B2 (ja) 2023-01-23
BR112020002619A2 (pt) 2020-07-28
US11654202B2 (en) 2023-05-23
US20210330820A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
AU2018314406B2 (en) Nanoemulsion of iodinated fatty acids for CT imaging
CA2893799C (en) Semifluorocarbon compound containing contrast agent
TW319763B (enExample)
IL285353B2 (en) ct contrast material to detect calcification
JP2020529441A5 (enExample)
CN105592862B (zh) 肝脏预饱和及其后造影剂的施用
JP2009531286A (ja) 造影剤
EA043372B1 (ru) Контрастный агент для компьютерной томографии
US20140065067A1 (en) Radiopaque iodinated products intended for use medical imaging and their methods
EA045963B1 (ru) Контрастный агент для кт для детекции кахексии
PT815072E (pt) Agentes de contraste de raios x para a tomografia e a urografia computadorizadas
JP2004115378A (ja) 水溶性ヨード化合物を含むリポソーム
JPWO2002028392A1 (ja) 脳循環障害治療剤

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: UNIVERSITE DE GENEVE

Free format text: FORMER NAME(S): UNIVERSITY OF GENEVA

FGA Letters patent sealed or granted (standard patent)